Item Type | Name |
Concept
|
Alleles
|
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Computer Simulation
|
Concept
|
Carcinoma in Situ
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Educational Status
|
Concept
|
Health Surveys
|
Concept
|
Mass Screening
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Genetic Carrier Screening
|
Concept
|
Health Services Accessibility
|
Concept
|
Hospitals, University
|
Concept
|
Neoplasm Staging
|
Concept
|
Population Surveillance
|
Concept
|
Radiation-Sensitizing Agents
|
Concept
|
Social Support
|
Concept
|
Cohort Studies
|
Concept
|
Selenomethionine
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Social Class
|
Concept
|
Single-Blind Method
|
Concept
|
Statistics as Topic
|
Concept
|
United States
|
Concept
|
Survival
|
Concept
|
Urban Population
|
Concept
|
Multicenter Studies as Topic
|
Concept
|
Genes, BRCA2
|
Concept
|
Neoplasms, Second Primary
|
Concept
|
Salvage Therapy
|
Concept
|
Chi-Square Distribution
|
Concept
|
Case-Control Studies
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
National Institutes of Health (U.S.)
|
Concept
|
Sample Size
|
Concept
|
Muscle, Skeletal
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Selective Estrogen Receptor Modulators
|
Concept
|
Sentinel Lymph Node Biopsy
|
Concept
|
Genes, BRCA1
|
Concept
|
Psychiatric Status Rating Scales
|
Concept
|
Surveys and Questionnaires
|
Concept
|
National Cancer Institute (U.S.)
|
Concept
|
Health Status Disparities
|
Concept
|
Senegal
|
Concept
|
Socioeconomic Factors
|
Concept
|
Stochastic Processes
|
Concept
|
Ubiquitin-Protein Ligases
|
Concept
|
Skin Neoplasms
|
Concept
|
Models, Statistical
|
Concept
|
Mastectomy, Segmental
|
Concept
|
Selection Bias
|
Concept
|
Survival Analysis
|
Concept
|
United States Department of Veterans Affairs
|
Concept
|
Survival Rate
|
Concept
|
Patient Selection
|
Concept
|
Karnofsky Performance Status
|
Concept
|
Stroke
|
Concept
|
Gene Silencing
|
Concept
|
SEER Program
|
Concept
|
Statistics, Nonparametric
|
Concept
|
Genes, erbB-2
|
Concept
|
Tumor Suppressor Proteins
|
Concept
|
STAT1 Transcription Factor
|
Concept
|
Body Surface Area
|
Concept
|
Data Interpretation, Statistical
|
Concept
|
Drug Administration Schedule
|
Concept
|
Follow-Up Studies
|
Concept
|
Longitudinal Studies
|
Concept
|
Prospective Studies
|
Concept
|
Retrospective Studies
|
Concept
|
Signal Transduction
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Disease-Free Survival
|
Academic Article
|
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
|
Academic Article
|
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
|
Academic Article
|
Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
|
Academic Article
|
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
|
Academic Article
|
Coronary heart disease mortality and adjuvant tamoxifen therapy.
|
Academic Article
|
Methods for bounding the marginal survival distribution.
|
Academic Article
|
Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.
|
Academic Article
|
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
|
Academic Article
|
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.
|
Academic Article
|
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
|
Academic Article
|
Occurrence of stroke with tamoxifen in NSABP B-24.
|
Academic Article
|
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
|
Academic Article
|
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.
|
Academic Article
|
Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
|
Academic Article
|
Differences in breast cancer prognosis among African-American and Caucasian women.
|
Academic Article
|
Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
|
Academic Article
|
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial.
|
Academic Article
|
MYC is amplified in BRCA1-associated breast cancers.
|
Academic Article
|
The role of cancer cooperative groups within the spectrum of cancer care.
|
Academic Article
|
Benefits and costs of interventions to improve breast cancer outcomes in African American women.
|
Academic Article
|
Is patient travel distance associated with survival on phase II clinical trials in oncology?
|
Academic Article
|
Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.
|
Academic Article
|
Statistical considerations in assessing molecular markers for cancer prognosis and treatment efficacy.
|
Academic Article
|
Mammographic density and breast cancer after ductal carcinoma in situ.
|
Academic Article
|
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.
|
Academic Article
|
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.
|
Academic Article
|
Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites.
|
Academic Article
|
How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.
|
Academic Article
|
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
|
Academic Article
|
Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
|
Academic Article
|
Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
|
Academic Article
|
Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-gamma pathway but not IL-12 or IL-18.
|
Academic Article
|
The ongoing search for the sources of the breast cancer survival disparity.
|
Academic Article
|
Comments on: Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients.
|
Academic Article
|
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
|
Academic Article
|
Early viewing of noninferiority trials in progress.
|
Academic Article
|
Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment.
|
Academic Article
|
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
|
Academic Article
|
Re: Racial disparities in cancer survival among randomized clinical trials of the Southwest Oncology Group.
|
Academic Article
|
A missing data approach to semi-competing risks problems.
|
Academic Article
|
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
|
Academic Article
|
A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
|
Academic Article
|
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
|
Academic Article
|
Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
|
Academic Article
|
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
|
Academic Article
|
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer.
|
Academic Article
|
Multiple imputation methods for inference on cumulative incidence with missing cause of failure.
|
Academic Article
|
p53 as a marker of prognosis in African-American women with breast cancer.
|
Academic Article
|
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07.
|
Academic Article
|
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
|
Academic Article
|
Predictors of competing mortality in advanced head and neck cancer.
|
Academic Article
|
Colorectal cancer model of health disparities: understanding mortality differences in minority populations.
|
Academic Article
|
The use and interpretation of competing risks regression models.
|
Academic Article
|
Diffusing capacity predicts long-term survival after lung resection for cancer.
|
Academic Article
|
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
|
Academic Article
|
Optimization of response classification criteria for patients with malignant pleural mesothelioma.
|
Academic Article
|
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
|
Academic Article
|
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
|
Academic Article
|
Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
|
Academic Article
|
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
|
Academic Article
|
Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.
|
Academic Article
|
Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials.
|
Academic Article
|
Semiparametric models for cumulative incidence functions.
|
Academic Article
|
Choice and interpretation of statistical tests used when competing risks are present.
|
Academic Article
|
Population-based survival-cure analysis of ER-negative breast cancer.
|
Academic Article
|
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).
|
Academic Article
|
Race and the prognostic influence of p53 in women with breast cancer.
|
Academic Article
|
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
|
Academic Article
|
Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials.
|
Academic Article
|
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
|
Academic Article
|
Disease volumes as a marker for patient response in malignant pleural mesothelioma.
|
Academic Article
|
Integrated phase II/III clinical trials in oncology: a case study.
|
Academic Article
|
Baseline comorbidities in a skin cancer prevention trial in Bangladesh.
|
Academic Article
|
A nomogram for individualized estimation of survival among patients with brain metastasis.
|
Academic Article
|
Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.
|
Academic Article
|
Multiple imputation methods for nonparametric inference on cumulative incidence with missing cause of failure.
|
Academic Article
|
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
|
Academic Article
|
Bayesian Hierarchical Multiresolution Hazard Model for the Study of Time-Dependent Failure Patterns in Early Stage Breast Cancer.
|
Academic Article
|
Bayesian approach for flexible modeling of semicompeting risks data.
|
Academic Article
|
Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
|
Academic Article
|
Assessing treatment benefit with competing risks not affected by the randomized treatment.
|
Academic Article
|
Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: Development and validation.
|
Academic Article
|
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02.
|
Academic Article
|
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.
|
Academic Article
|
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.
|
Academic Article
|
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
|
Academic Article
|
Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer.
|
Academic Article
|
Comparison of futility monitoring guidelines using completed phase III oncology trials.
|
Academic Article
|
Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.
|
Academic Article
|
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
|
Academic Article
|
A Multiresolution Hazard Model for Multicenter Survival Studies: Application to Tamoxifen Treatment in Early Stage Breast Cancer.
|
Academic Article
|
An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population.
|
Academic Article
|
Flexible modeling of the hazard rate and treatment effects in long-term survival studies.
|
Academic Article
|
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.
|
Academic Article
|
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features.
|
Academic Article
|
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer.
|
Academic Article
|
Detecting a Survival Benefit to Dose Escalation-Reply.
|
Academic Article
|
Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.
|
Academic Article
|
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
|
Academic Article
|
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.
|
Academic Article
|
Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx.
|
Academic Article
|
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
|
Academic Article
|
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
|
Award or Honor Receipt
|
Elected Fellow
|
Academic Article
|
A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.
|
Award or Honor Receipt
|
Inducted Member
|
Academic Article
|
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.
|
Academic Article
|
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.
|
Academic Article
|
Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials.
|
Academic Article
|
Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures?
|
Academic Article
|
Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology.
|
Academic Article
|
Disparities in Breast Cancer: Narrowing the Gap.
|
Academic Article
|
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.
|
Academic Article
|
Statistical Considerations in the Evaluation of Continuous Biomarkers.
|
Academic Article
|
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.
|
Award or Honor Receipt
|
Co-recipient, Statistical Partnership Among Academe, Industry, and Government (SPAIG) Award
|
Academic Article
|
Hematuria following Post-Prostatectomy Radiotherapy: Incidence Increases with Long-Term Followup.
|
Academic Article
|
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.
|
Concept
|
Tobacco Smoking
|
Concept
|
Symptom Assessment
|
Academic Article
|
Early Endpoints in High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies.
|
Academic Article
|
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.
|